← Back to Clinical Trials
Recruiting NCT03481075

NCT03481075 Patient Specific Biomechanical Modeling of Abdominal Aortic Aneurysm to Improve Aortic Endovascular Repair

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03481075
Status Recruiting
Phase —
Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Condition Aortic Aneurysm
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2020-10-01
Primary Completion 2025-09-29

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Biomechanical computer program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2020-10-01 with a primary completion date of 2025-09-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project is aiming at the integration of a biomechanical computer program with a guidance code to simulate the endovascular repair (EVAR) procedure of abdominal aortic aneurysm (AAA). The computational time associated with finite element simulation generally renders its usage impractical for real-time application. Based on data collected during clinical interventions and a priori knowledge of AAA and endovascular device mechanical modeling, the investigators are proposing a deformable registration between preoperative CT-scans and per-operative fluoroscopy that will take into account prior simulations of participant specific EVAR procedures. To avoid the computational cost of a full finite element simulation, the investigators propose a simplified and real-time compliant repetitive mechanical behaviour based on participant specific parameters. The results of this research will provide the Canadian industry with the first realistic deformable vascular geometry tool for live endovascular intervention guidance. The proposed biomechanical modeling can be translated to other vascular intervention procedure by adjusting the biomechanical parameters.

Eligibility Criteria

Inclusion Criteria: * Patients with a clinical indication for EVAR/FEVAR of AAA and meeting anatomic inclusion criteria on preoperative enhanced CT-scan compatible with an endovascular repair. * Willing and capable of providing informed consent Exclusion Criteria: * Contraindication to endovascular repair * Creatinine clearance \< 30ml/min * History of severe allergy to iodinated contrast (anaphylaxis, bronchospasm) * Absence of recent previous thin-slice enhanced CT-scanner examination (stent planning based on MRI examination or non-enhanced CT examination).

Contact & Investigator

Central Contact

Jennifer Satterthwaite, MSc

✉ jennifer.satterthwaite.chum@ssss.gouv.qc.ca

📞 514-890-8000

Principal Investigator

Gilles Soulez, MD,MSc

PRINCIPAL INVESTIGATOR

Centre hospitalier de l'Université de Montréal (CHUM)

Frequently Asked Questions

Who can join the NCT03481075 clinical trial?

This trial is open to participants of all sexes, studying Aortic Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03481075 currently recruiting?

Yes, NCT03481075 is actively recruiting participants. Contact the research team at jennifer.satterthwaite.chum@ssss.gouv.qc.ca for enrollment information.

Where is the NCT03481075 trial being conducted?

This trial is being conducted at Montreal, Canada.

Who is sponsoring the NCT03481075 clinical trial?

NCT03481075 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM). The principal investigator is Gilles Soulez, MD,MSc at Centre hospitalier de l'Université de Montréal (CHUM). The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology